Binding of human urokinase type plasminogen activator and plasminogen to Borrelia species

Journal of Infectious Diseases

Volumn 174, Issue 1, 1996, Pages 97-104

  Klempner, Mark S ^a   Noring, Richard ^b   Epstein, Mark P ^b   McCloud, Bilaal ^b   Rogers, Rick A ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN; FLUOROCHROME; PLASMIN; PLASMINOGEN; PROTEINASE; UROKINASE;

ARTICLE; BACTERIUM ADHERENCE; BACTERIUM ISOLATION; BORRELIA BURGDORFERI; CELL SURFACE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SPECIES DIFFERENCE;

EID: 0030055294     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.1.97     Document Type: Article

References (32)

1. Barbour AG, Hayes SF. Biology of Borrelia species. Microbiol Rev 1986; 50:381-400.
2. Shih CM, Pollack PJ, Telford SR III, Spielman A. Delayed dissemination of Lyme disease spirochetes from the site of deposition in the skin in mice. J Infect Dis 1992;166:827-31.
3. Shih CM, Pollack PJ, Telford SR III, Spielman A. Rapid dissemination by the agent of Lyme disease in hosts that permit fulminating infection. Infect Immun 1993;61:2396-9.
4. Lavoipierre MMJ, Riek RF. Observations on the feeding habits of Argasid ticks and on the effect of their bites on laboratory animals, together with a note on the production of coxal fluid by several of the species studied. Ann Trop Med Parasitol 1955;49:96-113.
5. Wannamaker LW, Matsen JM. Streptococci and streptococcal diseases. New York: Academic Press, 1972.
6. Abramson C. Staphylococcal enzymes. In: Cohen JO, ed. The staphylococci. New York: Wiley-Interscience, 1972:187-248.
7. Joiner KA. Other virulence factors. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Philadelphia: WB Saunders, 1992:23-9.
8. Klempner MS, Noring R, Epstein MP, et al. Binding of human plasminogen and urokinase type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis 1995;171:1258-65.
9. Klempner MS, Noring R, Epstein MP, et al. RA. Subversion of the host fibrinolytic pathway for invasion by the Lyme disease spirochete, Borrelia burgdorferi. In: Cevenini R, Sambri V, La Placa M, eds. Advances in Lyme borreliosis research. Bologna, Italy: Societa Editrice Esculapio, 1994:97-100.
10. Mayer M. Biochemical and biological aspects of the plasminogen activation system. Clin Biochem 1990;23:197-211.
11. Kuusela P, Ullberg M, Saksela O, Kronvall G. Tissue-type plasminogen activator-mediated activation of plasminogen on the surface of group A, C and G streptococci. Infect Immun 1992;60:196-201.
12. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD. A surface protease and the invasive character of plague. Science 1992; 258:1004-7.
13. Georgilis K, Peacocke M, Klempner MS. Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro. J Infect Dis 1992;166:440-4.
14. Sevier ED. Sensitive, solid-phase assay of proteolytic activity. Anal Biochem 1976;74:593-6.
15. Sogowa K, Takahashi K. Use of fluorescamine-labeled casein as a substrate for assay of proteinases. J Biochem 1978;83:1783-7.
16. Lottenberg R, Christensen U, Jackson CM, Coleman PL. Assay of coagulation proteases using peptide chromogenic and fiuorogenic substrates. Methods Enzymol 1981;80:341-61.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989;3:18.47-.52.
18. Kuusela P, Saksela O. Binding and activation of plasminogen at the surface of Staphylococcus aureus. Increase in affinity after conversion to the lys form of the ligand. Eur J Biochem 1990;193:759-65.
19. Ullberg M, Kronvall G, Wimen B. New receptors for human plasminogen on gram-positive cocci. APMIS 1989;97:996-1002.
20. Parkkinen J, Korhonen TK. Binding of plasminogen to Escherichia coli adhesion proteins. FEBS Lett 1989;250:437-40.
21. Berge A, Sjobring U. PAM, a novel plasminogen binding protein from Streptococcus pyogenes. J Biol Chem 1993;268:25417-24.
22. Wang H, Lottenberg R, Boyle MDP. Analysis of plasmin[ogen] acquisition by clinical isolates of group A streptococci incubated in human plasma. J Infect Dis 1994;169:143-9.
23. Holt SC. Anatomy and chemistry of spirochetes. Microbiol Rev 1978;42: 114-60.
24. Berg HC, Bromley DB, Charon NW. Leptospiral motility. Symp Soc Gen Microbiol 1978;28:285-95.
25. Klempner MS, Noring R, Rogers RA. Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis 1993; 167:1074-81.
26. 3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc Natl Acad Sci USA 1993;90:7059-63.
27. Isaacs RD. Borrelia burgdorferi bind to epithelial cell proteoglycans. J Clin Invest 1994;93:809-19.
28. Thomas DD, Comstock LE. Interaction of Lyme disease spirochetes with cultured eucaryotic cells. Infect Immun 1989;57:1324-6.
29. Comstock LE, Thomas DD. Penetration of endothelial cell monolayers by Borrelia burgdorferi. Infect Immun 1989;57:1626-8.
30. Szczepanski A, Furie MB, Benach JL, Lane BP, Fleit HB. Interaction between Borrelia burgdorferi and endothelium in vitro. J Clin Invest 1990;85:1637-47.
31. Hechemy KE, Samsonoff WA, Harris HL, Mckee M. Adherence and entry of Borrelia burgdorferi in Vero cells. J Med Microbiol 1992;36:229-38.
32. Barbour AG, Tessier SL, Todd WJ. Lyme disease spirochetes and Ixodes tick spirochetes share a common surface antigenic determinant as defined by monoclonal antibody. Infect Immun 1983;41:795-804.